Cencora (COR) Liabilities and Shareholders Equity (2009 - 2026)
Cencora's (COR) quarterly Liabilities and Shareholders Equity came in at $81.7 billion in Q1 2026, up 14.69% YoY from $71.2 billion in Q1 2025, and up 4.2% on a QoQ basis from $78.4 billion in Q4 2025.
Cencora (COR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Cencora (COR) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $81.7 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 14.69% year-over-year to $81.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $310.6 billion (up 13.29% YoY) and the FY2025 annual result came in at $76.6 billion, up 14.14% from the prior year.
- Liabilities and Shareholders Equity advanced to $81.7 billion in Q1 2026, from $78.4 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $81.7 billion in Q1 2026 to a low of $56.6 billion in Q3 2022.
- A 5-year average of $66.2 billion and a median of $64.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- The widest YoY moves for Liabilities and Shareholders Equity: up 21.92% in 2022, down 1.36% in 2022.
- Tracing COR's Liabilities and Shareholders Equity over 5 years: stood at $57.9 billion in 2022, then gained by 11.71% to $64.7 billion in 2023, then rose by 6.75% to $69.1 billion in 2024, then climbed by 13.48% to $78.4 billion in 2025, then advanced by 4.2% to $81.7 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $81.7 billion (Q1 2026), $78.4 billion (Q4 2025), and $76.6 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 88.33 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 83.81 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 57.30 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 11.38 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 189.63 Mn |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 74.55 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.11 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 279.33 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 61.46 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.81 Bn |
| Mar 31, 2026 | 81.65 Bn |
| Dec 31, 2025 | 78.36 Bn |
| Sep 30, 2025 | 76.59 Bn |
| Jun 30, 2025 | 73.96 Bn |
| Mar 31, 2025 | 71.19 Bn |
| Dec 31, 2024 | 69.05 Bn |
| Sep 30, 2024 | 67.10 Bn |
| Jun 30, 2024 | 66.77 Bn |
| Mar 31, 2024 | 63.87 Bn |
| Dec 31, 2023 | 64.69 Bn |
| Sep 30, 2023 | 62.56 Bn |
| Jun 30, 2023 | 61.18 Bn |
| Mar 31, 2023 | 58.77 Bn |
| Dec 31, 2022 | 57.91 Bn |
| Sep 30, 2022 | 56.56 Bn |
| Jun 30, 2022 | 57.17 Bn |
| Mar 31, 2022 | 57.31 Bn |
| Dec 31, 2021 | 57.58 Bn |
| Sep 30, 2021 | 57.34 Bn |